We are live on ! Find out more
BL

Bleichroeder LP Portfolio holdings

AUM $559M Turnover 17.24%
1-Year Est. Return 83.7%
This Fund
S&P 500
This Quarter Est. Return
+27.59%
1 Year Est. Return
+83.7%
3 Year Est. Return
+202.15%
5 Year Est. Return
+208.71%
10 Year Est. Return
–
AUM
$592M
AUM Growth
+$78.5M
Cap. Flow
+$48.3M
Cap. Flow %
8.16%
Top 10 Hldgs %
62.58%
Holding
88
New
16
Increased
4
Reduced
1
Closed
7
Avg Time Held
0.8 years
Top 10 Avg Time Held
0.8 years
Top 20 Avg Time Held
0.9 years

Top Buys

Rank Stock Value
1
FNCH icon
Finch Therapeutics Group, Inc. Common Stock
FNCH
+$13.8M
2
ISLE
Isleworth Healthcare Acquisition Corporation Common stock
ISLE
+$9.66M
3
FLNA icon
Filana Therapeutics
FLNA
+$8.48M
4
CNST
Constellation Pharmaceuticals, Inc.
CNST
+$5.53M
5
GBT
Global Blood Therapeutics, Inc.
GBT
+$4.6M

Top Sells

Rank Stock Value
1
TGTX icon
TG Therapeutics
TGTX
+$3.9M
2
IDN icon
Intellicheck
IDN
+$2.99M
3
EOSEW icon
Eos Energy Enterprises Warrant
EOSEW
+$2.08M
4
HCARU
Healthcare Services Acquisition Corporation Unit
HCARU
+$1.53M
5
ORTX
Orchard Therapeutics plc American Depositary Shares
ORTX
+$1.13M

Sector Composition

Rank Sector Weight
1 Healthcare 25.7%
2 Miscellaneous 14.31%
3 Industrials 13.57%
4 Consumer Discretionary 12.6%
5 Materials 9.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
CELC icon
51
Celcuity
CELC
$2.95B
$717K 0.12%
+50,000
New +$711K
2021 Q1
0 quarters
ARKOW icon
52
DELISTED
ARKO Corp Warrant
ARKOW
$683K 0.12%
333,333
– –
2020 Q4
1 quarter
LBTYA icon
53
Liberty Global Class A
LBTYA
$2.74B
$590K 0.1%
22,989
– –
2019 Q4
5 quarters
BATRK icon
54
Atlanta Braves Holdings Series B
BATRK
$3.17B
$576K 0.1%
20,717
– –
2020 Q2
3 quarters
RTX icon
55
RTX Corp
RTX
$252B
$464K 0.08%
6,000
– –
2020 Q2
3 quarters
FGNA.WS
56
DELISTED
FG New America Acquisition Corp. Warrants, each whole warrant exercisable for one share of Class A c
FGNA.WS
$385K 0.07%
250,000
– –
2020 Q4
1 quarter
LHX icon
57
L3Harris
LHX
$44.8B
$324K 0.05%
1,600
– –
2019 Q4
5 quarters
XFOR icon
58
X4 Pharmaceuticals
XFOR
$262M
$308K 0.05%
1,191
– –
2019 Q4
5 quarters
BATRA icon
59
Atlanta Braves Holdings Series A
BATRA
$3.51B
$295K 0.05%
10,356
– –
2019 Q4
5 quarters
CARR icon
60
Carrier Global
CARR
$45.3B
$253K 0.04%
6,000
– –
2020 Q2
3 quarters
ISLEW
61
DELISTED
Isleworth Healthcare Acquisition Corporation Warrant
ISLEW
$233K 0.04%
+500,000
New +$239K
2021 Q1
0 quarters
LILAK icon
62
Liberty Latin America Class C
LILAK
$1.6B
$214K 0.04%
18,174
– –
2020 Q2
3 quarters
LGF.B
63
DELISTED
Lions Gate Entertainment Corp. Class B Non-Voting Shares
LGF.B
$212K 0.04%
16,413
– –
2019 Q4
5 quarters
OTIS icon
64
Otis Worldwide
OTIS
$26.8B
$205K 0.03%
3,000
– –
2020 Q2
3 quarters
PHYS icon
65
Sprott Physical Gold
PHYS
$14.9B
$168K 0.03%
12,540
– –
2019 Q4
5 quarters
ROCRU
66
DELISTED
Roth CH Acquisition III Co. Unit
ROCRU
$150K 0.03%
+15,000
New +$150K
2021 Q1
0 quarters
CZOO icon
67
DELISTED
Cazoo Group Ltd
CZOO
$103K 0.02%
5
– –
2020 Q4
1 quarter
BNY icon
68
Bank of New York Mellon
BNY
$96.4B
$95K 0.02%
2,000
– –
2020 Q1
4 quarters
TER icon
69
Teradyne
TER
$53.7B
$73K 0.01%
600
– –
2020 Q2
3 quarters
CDNS icon
70
Cadence Design Systems
CDNS
$89.3B
$72K 0.01%
525
– –
2020 Q2
3 quarters
XLNX
71
DELISTED
Xilinx Inc
XLNX
$66K 0.01%
530
– –
2020 Q2
3 quarters
MO icon
72
Altria Group
MO
$123B
$61K 0.01%
1,200
– –
2020 Q2
3 quarters
LITE icon
73
Lumentum
LITE
$78.8B
$60K 0.01%
660
– –
2020 Q2
3 quarters
XOM icon
74
ExxonMobil
XOM
$718B
$60K 0.01%
1,075
– –
2020 Q2
3 quarters
ABBV icon
75
AbbVie
ABBV
$501B
$56K 0.01%
515
– –
2020 Q2
3 quarters
1 2
3
4

Similar funds

NFW
Noble Family Wealth Clearwater, Florida $559M AUM 24.35% 1-Year Est. Return
SCM
Soros Capital Management New York $559M AUM 171.77% 1-Year Est. Return
PHC
Palidye Holdings (Caymans) Grand Cayman, Cayman Islands $559M AUM 1.08% 1-Year Est. Return
EPM
Equitec Proprietary Markets Chicago, Illinois $559M AUM 230.29% 1-Year Est. Return
BCM
Brasada Capital Management Houston, Texas $558M AUM 21.68% 1-Year Est. Return
FAM
Frontier Asset Management Sheridan, Wyoming $558M AUM 22.41% 1-Year Est. Return
WDG
Wealth Dimensions Group Cincinnati, Ohio $558M AUM 20.63% 1-Year Est. Return
OC
Opal Capital Boca Raton, Florida $560M AUM

Bleichroeder LP's Q1 2021 Portfolio in Review

As of Q1 2021, Bleichroeder LP held 88 positions worth $592M, up 15% from $514M the previous quarter. Its ten largest holdings account for 63% of the portfolio.

Bleichroeder LP deployed $48.3M of net new capital in Q1 2021, opening 16 new positions and adding to 4 existing holdings. Its largest new stake was Finch Therapeutics Group, Inc. Common Stock: 27,014 shares worth $13.1M.

By sector, the portfolio is most concentrated in Healthcare at 26% of assets, up from 22% a quarter earlier, followed by Miscellaneous and Industrials.

On the sell side, the largest reduction was Intellicheck, an estimated $2.99M trimmed.

  • Bleichroeder LP's largest Q1 2021 buy was Finch Therapeutics Group, Inc. Common Stock: 27,014 shares worth $13.1M.
  • Bleichroeder LP added most to Filana Therapeutics in Q1 2021, an estimated $8.48M increase.
  • Bleichroeder LP's biggest Q1 2021 reduction was Intellicheck, cutting an estimated $2.99M.
  • Bleichroeder LP fully exited TG Therapeutics in Q1 2021, selling an estimated $3.9M.
  • Bleichroeder LP's ten largest holdings make up 63% of its $592M portfolio in Q1 2021.
  • Bleichroeder LP opened 16 new positions and closed 7 in Q1 2021.
  • Bleichroeder LP's portfolio value rose 15% quarter-over-quarter to $592M.

Based on Bleichroeder LP's 13F filing for Q1 2021, filed 17 May 2021.